195P Health-related quality of life outcomes in SOLTI VALENTINE: A trial of neoadjuvant HER3-DXd +/- letrozole for high-risk hormone receptor positive/HER2-negative early breast cancerGuillermo Villacampa, Ana Muntañola Prat, F.J. Salvador Bofill et al.|ESMO Open|2025Cited by 1
Validation of New International Prognostic Scores, Including Baseline Peripheral Blood Variables, in Patients with Diffuse Large B-Cell Lymphoma and HIV Infection Treated with R-CHOP and Combined Antiretroviral Therapy. Retrospective Study from Spanish Lymphoma Group GeltamoMaría Luisa López Huguet, José‐Tomás Navarro, Mireia Morgades et al.|Blood|2021Cited by 0